Contents
- Part 1 Preliminary
- Part 2 Injuries and diseases attributable to specified defence service
- Part 3 Secondary injuries and diseases attributable to any defence service
- Part 4 diseases attributable to certain defence service involving abuse
- Part 5 Diseases attributable to Point Cook firefighting work
- Part 6 Diseases attributable to F-111 deseal/reseal work
- Part 7 Cancers attributable to firefighting work
- Part 8 Occupational diseases attributable to specified defence service
- Part 9 Occupational asthma attributable to specified defence service
Part 1 · Preliminary
1Name#
This instrument is the Military Rehabilitation and Compensation (Injuries and Diseases Attributable to Defence Service—Presumptive Liability) Determination 2026.
3Authority#
(1)This instrument is made under subsection 27A(3) of the Military Rehabilitation and Compensation Act 2004.
4Definitions#
Note: A number of expressions used in this instrument are defined in the Act, including the following:
(a) Commission;
(b) defence service;
(c) full-time service;
(d) disease;
(e) injury;
(f) member;
(g) non-warlike service;
(h) peacetime service.
In this instrument:
accepted condition means a service injury or service disease for which the Commission has accepted liability under the Act.
maximum redress or reparation scheme payment means one of the following redress or reparation scheme payments:
(a)a category 4 Defence Abuse Response Taskforce payment; or
(b)a tier 1 Defence Force Ombudsman Reparation Scheme payment; or
(c)a maximum National Redress Scheme for victims of institutional child sexual abuse payment.
onset means:
(a)in relation to an injury—the time when the injury was sustained;
(b)in relation to a disease—the time when all the signs and symptoms of the disease were first present as determined by a relevant medical practitioner.
redress or reparation scheme payment means a redress or reparation payment in relation to abuse in the Defence Force from or under any of the following:
(a)the Defence Abuse Response Taskforce; or
(b)the Defence Force Ombudsman Reparation Scheme; or
(c)the National Redress Scheme for victims of institutional child sexual abuse.
warlike service includes:
(a)warlike service as defined in the Act; and
(b)qualifying service as defined in section 7A of the Veterans’ Entitlements Act 1986.
Part 2 · Injuries and diseases attributable to specified defence service
6Interpretation of this Part#
For the purposes of this Part, a reference to a kind of defence service, including peacetime service, warlike service and non-warlike service, is a reference to full-time service (whether consecutive or not).
7Attributable injuries and diseases#
An injury or disease specified in column 1 of an item in the table is attributable
to the kind of defence service specified in column 2 of the item.
| Column 1 | Column 2 | |
| Item | Injury/disease | Kind of defence service |
| 1 | Achilles tendinopathy, but only if onset occurs:(a) during the defence service specified for this item; or(b) within 4 weeks after the last day of defence service specified for this item. | Defence service:(a) for more than 28 days; and(b) excluding the first 28 days of defence service. |
| 2 | Acute articular cartilage tear, but only if onset occurs during the defence service specified for this item. | Any defence service. |
| 3 | Acute meniscal tear of the knee, but only if onset occurs during the defence service specified for this item. | Any defence service. |
| 4 | Adjustment disorder, but only if onset occurs:(a) during the defence service specified for this item; or(b) within 3 months after the last day of defence service specified for this item. | Warlike service:(a) for more than 28 days; and(b) excluding the first 28 days of warlike service. |
| 5 | Anxiety disorder, but only if onset occurs:(a) during the defence service specified for this item; or(b) within 5 years after the last day of defence service specified for this item. | Warlike service:(a) for more than 28 days; and(b) excluding the first 28 days of warlike service. |
| 6 | Cataract | Defence service being:(a) peacetime service for at least 56 weeks; or(b) warlike service or non-warlike service for at least 29 weeks. |
| 7 | Chondromalacia patella, but only if onset occurs:(a) during the defence service specified for this item; or(b) within 4 weeks after the last day of defence service specified for this item | Defence service:(a) for more than 28 days; and(b) excluding the first 28 days of defence service. |
| 8 | Cut, stab, abrasion or laceration, but only if onset occurs during the defence service specified for this item. | Any defence service. |
| 9 | Dislocation of a joint or subluxation of a joint, but only if onset occurs during the defence service specified for this item. | Any defence service. |
| 10 | Explosive blast injury, but only if onset occurs during the defence service specified for this item. | Any defence service. |
| 11 | Femoroacetabular impingement syndrome, but only if onset occurs:(a) during the defence service specified for this item; or(b) within 5 years after the last day of defence service specified for this item. | Defence service:(a) for more than 5 years; and(b) excluding the first 5 years of defence servicein the following roles:(c) special forces, including:(i) Special Air Service Regiment; and(ii) Commandos; and(iii) Special Operations Engineer Regiment; and(iv) Clearance Divers; or(d) Airfield Defence Guards;(e) infantry; or(f) engineers. |
| 12 | Fracture, but only if onset occurs during the defence service specified for this item. | Any defence service. |
| 13 | Gluteal tendinopathy, but only if onset occurs:(a) during the defence service specified for this item; or(b) within 4 weeks after the last day of defence service specified for this item. | Defence service:(a) for more than 28 days; and(b) excluding the first 28 days of defence service. |
| 14 | Gunshot injury, but only if onset occurs during the defence service specified for this item. | Any defence service. |
| 15 | Heat-induced burn, but only if onset occurs during the defence service specified for this item. | Any defence service. |
| 16 | Iliotibial band syndrome (runner’s knee), but only if onset occurs:(a) during the defence service specified for this item; or(b) within 4 weeks after the last day of defence service specified for this item. | Defence service:(a) for more than 28 days; and(b) excluding the first 28 days of defence service. |
| 17 | Internal derangement of the knee, but only if onset occurs:(a) during the defence service specified for this item; or(b) within one year after the last day of defence service specified for this item. | Any defence service. |
| 18 | Joint instability, but only if onset occurs during the defence service specified for this item. | Any defence service. |
| 19 | Labral tear, but only if onset occurs during the defence service specified for this item. | Any defence service. |
| 20 | Medial tibial stress syndrome (shin splints), but only if onset occurs:(a) during the defence service specified for this item; or(b) within 4 weeks after the last day of defence service specified for this item. | Defence service:(a) for more than 28 days; and(b) excluding the first 28 days of defence service. |
| 21 | Merkel cell carcinoma | Defence service being:(a) peacetime service for at least 56 weeks; or(b) warlike service or non-warlike service for at least 29 weeks. |
| 22 | Osteoarthritis (of a joint of a lower limb), but only if onset occurs:(a) during the defence service specified for this item; or(b) within 25 years after the last day of defence service specified for this item. | Peacetime service:(a) for more than 200 days; and(b) excluding the first 200 days of peacetime service. |
| 23 | Osteoarthritis (of a joint of a lower limb) | Warlike or non-warlike service:(a) for more than 133 days; and(b) excluding the first 133 days of warlike or non-warlike service. |
| 24 | Otitic barotrauma, but only if onset occurs during the defence service specified for this item. | Defence service:(a) in special forces, including:(i) Special Air Service Regiment; and(ii) Commandos; and(iii) Special Operations Engineer Regiment; or(b) as an engineer with a role involving the disposal/use of explosive ordinance; or(c) as a clearance/ships’ diver; or(d) as a submariner; or(e) as a pilot or aircrew; or(f) as aeromedical evacuation personnel; or(g) as underwater medicine medical personnel (officer or medic). |
| 25 | Patellar tendinopathy, but only if onset occurs:(a) during the defence service specified for this item; or(b) within 4 weeks after the last day of defence service specified for this item. | Defence service:(a) for more than 28 days; and(b) excluding the first 28 days of defence service. |
| 26 | Pinguecula (conjunctival degeneration) | Defence service being:(a) peacetime service for at least 56 weeks; or(b) warlike service or non-warlike service for at least 29 weeks. |
| 27 | Plantar fasciitis, but only if onset occurs:(a) during the defence service specified for this item; or(b) within 2 months after the last day of defence service specified for this item. | Defence service:(a) for more than 60 days; and(b) excluding the first 60 days of defence service. |
| 28 | Posttraumatic stress disorder | Warlike service:(a) for more than 28 days; and(b) excluding the first 28 days of warlike service. |
| 29 | Primary malignant melanoma of the skin | Defence service being:(a) peacetime service for at least 56 weeks; or(b) warlike service or non-warlike service for at least 29 weeks. |
| 30 | Primary malignant neoplasm of the eye | Defence service being:(a) peacetime service for at least 56 weeks; or(b) warlike service or non-warlike service for at least 29 weeks. |
| 31 | Primary non-melanoma malignant neoplasm (NMMN) of the skin | Defence service being:(a) peacetime service for at least 56 weeks; or(b) warlike service or non-warlike service for at least 29 weeks. |
| 32 | Pterygium | Defence service being:(a) peacetime service for at least 56 weeks; or(b) warlike service or non-warlike service for at least 29 weeks. |
| 33 | Retrocalcaneal heel bursitis, but only if onset occurs:(a) during the defence service specified for this item; or(b) within 4 weeks after the last day of defence service specified for this item. | Defence service:(a) for more than 28 days; and(b) excluding the first 28 days of defence service. |
| 34 | Rotator cuff syndrome, but only if onset occurs:(a) during the defence service specified for this item; or(b) within one month after the last day of defence service specified for this item. | Peacetime service:(a) for more than 210 days; and(b) excluding the first 210 days of peacetime service. |
| 35 | Rotator cuff syndrome, but only if onset occurs:(a) during the defence service specified for this item; or(b) within one month after the last day of defence service specified for this item. | Warlike or non-warlike service:(a) for more than 120 days; and(b) excluding the first 120 days of warlike or non-warlike service. |
| 36 | Sensorineural hearing loss | Any defence service. |
| 37 | Sinus barotrauma, but only if onset occurs during the defence service specified for this item. | Defence service:(a) in special forces, including:(i) Special Air Service Regiment; and(ii) Commandos; and(iii) Special Operations Engineer Regiment; or(b) as an engineer with a role involving the disposal/use of explosive ordinance; or(c) as a clearance/ships’ diver; or(d) as a submariner; or(e) as a pilot or aircrew; or(f) as aeromedical evacuation personnel; or(g) as underwater medicine medical personnel (officer or medic). |
| 38 | Solar keratosis | Defence service being:(a) peacetime service for at least 56 weeks; or(b) warlike service or non-warlike service for at least 29 weeks. |
| 39 | Sprain and strain, but only if onset occurs during the defence service specified for this item. | Any defence service. |
| 40 | Thoracolumbar intervertebral disc prolapse, but only if onset occurs:(a) during the defence service specified for this item; or(b) within 5 years after the last day of defence service specified for this item. | Peacetime service:(a) for more than 148 weeks; and(b) excluding the first 148 weeks of peacetime service. |
| 41 | Thoracolumbar intervertebral disc prolapse, but only if onset occurs:(a) during the defence service specified for this item; or(b) within 10 years after the last day of defence service specified for this item. | Warlike or non-warlike service:(a) for more than 504 days; and(b) excluding the first 504 days of warlike or non-warlike service. |
| 42 | Thoracolumbar spondylosis (also known as thoracic and lumbar spondylosis), but only if onset occurs:(a) during the defence service specified for this item; or(b) within 25 years after the last day of defence service specified for this item. | Peacetime service:(a) for more than 200 days; and(b) excluding the first 200 days of peacetime service. |
| 43 | Thoracolumbar spondylosis (also known as thoracic and lumbar spondylosis) | Warlike or non-warlike service:(a) for more than 133 days; and(b) excluding the first 133 days of warlike or non-warlike service. |
| 44 | Tinea, but only if onset occurs:(a) during the defence service specified for this item; or(b) within 28 days after the last day of defence service specified for this item. | Any defence service. |
| 45 | Tinnitus | Any defence service. |
| 46 | Traumatic contusion or haematoma, but only if onset occurs during the defence service specified for this item. | Any defence service. |
| 47 | Trochanteric bursitis, but only if onset occurs:(a) during the defence service specified for this item; or(b) within 4 weeks after the last day of defence service specified for this item. | Defence service:(a) for more than 28 days; and(b) excluding the first 28 days of defence service. |
Part 3 · Secondary injuries and diseases attributable to any defence service
8Attributable injuries and diseases#
An injury or disease specified in the table is attributable to any defence service.
| Item | Injury/disease |
| 1 | Alcohol use disorder, but only if at least one of the following is an accepted condition that is present at the time of onset:(a) substance use disorder;(b) depressive disorder. |
| 2 | Anosmia, but only if alcohol use disorder is an accepted condition that is present at the time of onset. |
| 3 | Aortic aneurysm or aortic wall disorder, but only if hypertension is an accepted condition that is present before onset. |
| 4 | Aortic stenosis, but only if at least one of the following is an accepted condition that is present before onset:(a) diabetes mellitus;(b) hypertension. |
| 5 | Atrial fibrillation or atrial flutter, but only if hypertension is an accepted condition that is present at the time of onset. |
| 6 | Bipolar disorder, but only if substance use disorder is an accepted condition that is present at the time of onset. |
| 7 | Bronchiectasis, but only if inflammatory bowel disease is an accepted condition that is present at the time of onset. |
| 8 | Cardiomyopathy, but only if diabetes mellitus is an accepted condition that is present at the time of onset. |
| 9 | Carotid artery disease, but only if at least one of the following is an accepted condition that is present before onset:(a) diabetes mellitus;(b) hypertension. |
| 10 | Cataract, but only if diabetes mellitus is an accepted condition that is present before onset. |
| 11 | Cerebrovascular accident, but only if diabetes mellitus is an accepted condition that is present at the time of onset. |
| 12 | Chronic pruritus ani, but only if at least one of the following is an accepted condition that is present at the time of onset:(a) diabetes mellitus;(b) inflammatory bowel disease. |
| 13 | Conjunctivitis, but only if diabetes mellitus is an accepted condition that is present at the time of onset. |
| 14 | Depressive disorder, but only if alcohol use disorder is an accepted condition that is present at the time of onset. |
| 15 | Dupuytren disease, but only if:(a) diabetes mellitus is an accepted condition that is present before onset; or(b) alcohol use disorder is an accepted condition that is present at the time of onset. |
| 16 | Erectile dysfunction, but only if at least one of the following is an accepted condition that is present at the time of onset:(a) depressive disorder;(b) diabetes mellitus;(c) hypertension. |
| 17 | Female sexual dysfunction, but only if depressive disorder is an accepted condition that is present at the time of onset. |
| 18 | Gingivitis, but only if diabetes mellitus is an accepted condition that is present at the time of onset. |
| 19 | Heart block, but only if diabetes mellitus is an accepted condition that is present at the time of onset. |
| 20 | IgA nephropathy, but only if inflammatory bowel disease is an accepted condition that is present at the time of onset. |
| 21 | Immune thrombocytopaenia, but only if inflammatory bowel disease is an accepted condition that is present at the time of onset. |
| 22 | Ischaemic heart disease, but only if at least one of the following is an accepted condition that is present before onset:(a) diabetes mellitus;(b) hypertension. |
| 23 | Non-aneurysmal aortic atherosclerotic disease, but only if at least one of the following is an accepted condition that is present before onset:(a) diabetes mellitus;(b) hypertension. |
| 24 | Non-Hodgkin lymphoma, but only if inflammatory bowel disease is an accepted condition that is present before onset. |
| 25 | Osteomyelitis, but only if diabetes mellitus is an accepted condition that is present at the time of onset. |
| 26 | Otitis externa, but only if diabetes mellitus is an accepted condition that is present at the time of onset. |
| 27 | Periodontitis, but only if diabetes mellitus is an accepted condition that is present at the time of onset. |
| 28 | Peripheral artery disease, but only if at least one of the following is an accepted condition that is present before onset:(a) diabetes mellitus;(b) hypertension. |
| 29 | Peripheral neuropathy, but only if diabetes mellitus is an accepted condition that is present at the time of onset. |
| 30 | Porphyria cutanea tarda, but only if alcohol use disorder is an accepted condition that is present at the time of onset. |
| 31 | Renal artery atherosclerotic disease, but only if diabetes mellitus is an accepted condition that is present before onset. |
| 32 | Renal stone disease, but only if at least one of the following is an accepted condition that is present at the time of onset:(a) diabetes mellitus;(b) inflammatory bowel disease. |
| 33 | Retinal vascular occlusion, but only if at least one of the following is an accepted condition that is present before onset:(a) diabetes mellitus;(b) hypertension. |
| 34 | Sick sinus syndrome, but only if hypertension is an accepted condition that is present at the time of onset. |
| 35 | Steatohepatitis, but only if diabetes mellitus is an accepted condition that is present at the time of onset. |
| 36 | Subarachnoid haemorrhage, but only if hypertension is an accepted condition that is present at the time of onset. |
| 37 | Subdural haematoma, but only if alcohol use disorder is an accepted condition that is present at the time of onset. |
| 38 | Substance use disorder, but only if at least one of the following is an accepted condition that is present at the time of onset:(a) alcohol use disorder;(b) depressive disorder. |
| 39 | Suicide or attempted suicide, but only if at least one of the following is an accepted condition that is present at the time of onset:(a) alcohol use disorder;(b) depressive disorder;(c) substance use disorder. |
| 40 | Tinea, but only if diabetes mellitus is an accepted condition that is present at the time of onset. |
| 41 | Tooth wear (attrition), but only if bruxism is an accepted condition that is present at the time of onset. |
| 42 | Tooth wear (tooth erosion), but only if alcohol use disorder is an accepted condition that is present at the time of onset. |
| 43 | Trigeminal neuropathy, but only if diabetes mellitus is an accepted condition that is present at the time of onset. |
| 44 | Trigger finger, but only if diabetes mellitus is an accepted condition that is present before onset. |
| 45 | Tuberculosis, but only if alcohol use disorder is an accepted condition that is present before onset. |
Part 4 · diseases attributable to certain defence service involving abuse
9Attributable injuries and diseases#
An injury or disease specified in the table below is attributable to defence service involving abuse in respect of which the person with the injury or disease received a redress or reparation scheme payment.
| Item | Injury/disease |
| 1 | Adjustment disorder, but only if onset occurs:(a) during the defence service involving abuse; or(b) within 3 months after the last day of defence service involving abuse. |
| 2 | Alcohol use disorder, but only if onset occurs:(a) during the defence service involving abuse; or(b) within 6 months after the last day of defence service involving abuse. |
| 3 | Anxiety disorder, but only if onset occurs:(a) during the defence service involving abuse; or(b) within 6 months after the last day of defence service involving abuse. |
| 4 | Bipolar disorder, but only if onset occurs:(a) during the defence service involving abuse; or(b) within 6 months after the last day of defence service involving abuse. |
| 5 | Chronic insomnia disorder, but only if onset occurs:(a) during the defence service involving abuse; or(b) within one year after the last day of defence service involving abuse. |
| 6 | Depressive disorder, but only if onset occurs:(a) during the defence service involving abuse; or(b) within 6 months after the last day of defence service involving abuse. |
| 7 | Eating disorder, but only if onset occurs:(a) during the defence service involving abuse; or(b) within 2 years after the last day of defence service involving abuse. |
| 8 | Panic disorder, but only if onset occurs:(a) during the defence service involving abuse; or(b) within 2 years after the last day of defence service involving abuse. |
| 9 | Substance use disorder, but only if onset occurs:(a) during the defence service involving abuse; or(b) within 6 months after the last day of defence service involving abuse. |
| 10 | Suicide and attempted suicide, but only if it occurs:(a) during the defence service involving abuse; or(b) within 10 years after the last day of defence service involving abuse. |
An injury or disease specified in the table below is attributable to warlike or non-warlike service involving abuse in respect of which the person with the injury or disease received a redress or reparation scheme payment.
| Item | Injury/disease |
| 1 | Bruxism, but only if onset occurs during the warlike or non-warlike service involving abuse. |
| 2 | Herpes simplex (orofacial and genital herpes simplex only), but only if onset occurs during the warlike or non-warlike service involving abuse. |
| 3 | Inflammatory bowel disease, but only if onset occurs:(a) during the warlike or non-warlike service involving abuse; or(b) within 30 days after the last day of warlike or non-warlike service involving abuse. |
| 4 | Irritable bowel syndrome, but only if onset occurs:(a) during the warlike or non-warlike service involving abuse; or(b) within one year after the last day of warlike or non-warlike service involving abuse. |
| 5 | Psoriasis, but only if onset occurs:(a) during the warlike or non-warlike service involving abuse; or(b) within 6 months after the last day of warlike or non-warlike service involving abuse. |
| 6 | Tension-type headache, but only if onset occurs:(a) during the warlike or non-warlike service involving abuse; or(b) within one year after the last day of warlike or non-warlike service involving abuse. |
An injury or disease specified in the table below is attributable to defence service involving abuse in respect of which the person with the injury or disease received a maximum redress or reparation scheme payment.
| Item | Injury/disease |
| 1 | Acute stress disorder, but only if onset occurs:(a) during the defence service involving abuse; or(b) within 30 days after the last day of defence service involving abuse. |
| 2 | Adjustment disorder, but only if onset occurs:(a) during the defence service involving abuse; or(b) within 3 months after the last day of defence service involving abuse. |
| 3 | Alcohol use disorder, but only if onset occurs:(a) during the defence service specified for involving abuse; or(b) within 2 years after the last day of defence service involving abuse . |
| 4 | Anxiety disorder, but only if onset occurs:(a) during the defence service involving abuse; or(b) within 2 years after the last day of defence service involving abuse. |
| 5 | Bipolar disorder, but only if onset occurs:(a) during the defence service involving abuse; or(b) within 6 months after the last day of defence service involving abuse. |
| 6 | Depressive disorder, but only if onset occurs:(a) during the defence service involving abuse; or(b) within 2 years after the last day of defence service involving abuse. |
| 7 | Female sexual dysfunction, but only if onset occurs:(a) during the defence service involving abuse; or(b) within 5 years after the last day of defence service involving abuse. |
| 8 | Panic disorder, but only if onset occurs:(a) during the defence service specified involving abuse; or(b) within 2 years after the last day of defence service involving abuse. |
| 9 | Personality disorder, but only if onset occurs:(a) during the defence service specified involving abuse; or(b) within one year after the last day of defence service involving abuse. |
| 10 | Posttraumatic stress disorder, but only if onset occurs:(a) during the defence service involving abuse; or(b) after the last day of defence service involving abuse. |
| 11 | Schizophrenia, but only if onset occurs:(a) during the defence service involving abuse; or(b) within 3 months after the last day of defence service involving abuse. |
| 12 | Substance use disorder, but only if onset occurs:(a) during the defence service involving abuse; or(b) within 2 years after the last day of defence service involving abuse. |
| 13 | Suicide and attempted suicide, but only if it occurs:(a) during the defence service involving abuse; or(b) after the last day of defence service involving abuse. |
Part 5 · Diseases attributable to Point Cook firefighting work
10Attributable diseases#
A disease specified in the table is attributable to defence service:
(a)at RAAF Base Point Cook between 1 January 1957 and 31 December 1986; and
(b)involving work relating to any of the following:
(i) firefighting; or
(ii) participating in a firefighting training course; or
(iii) instructing participants in a firefighter training course.
| Item | Disease |
| 1 | Acquired colour vision deficiency |
| 2 | Agoraphobia with panic disorder |
| 3 | Anxiety |
| 4 | Bipolar disorder |
| 5 | Bowel polyps |
| 6 | Cauda equina syndrome |
| 7 | Depression |
| 8 | Diverticular disease |
| 9 | Dysplastic naevus |
| 10 | Eczema or dermatitis |
| 11 | Erectile dysfunction |
| 12 | Impaired cognition |
| 13 | Irritable bowel disorder |
| 14 | Liver disease (excluding diabetes) |
| 15 | Memory loss |
| 16 | Mixed connective tissue disease |
| 17 | Multiple sclerosis |
| 18 | Myeloproliferative disorders |
| 19 | Neurogenic bladder |
| 20 | Non-alcoholic toxic encephalopathy |
| 21 | Pancreatic disease |
| 22 | Panic disorders |
| 23 | Parkinson disease |
| 24 | Peripheral neuropathy |
| 25 | Primary malignant neoplasms |
| 26 | Sarcoidosis |
| 27 | Sleep disorders with a neurological basis |
| 28 | Spinal muscular atrophy |
| 29 | Systemic lupus erythematosus |
| 30 | Ulcerative colitis/Crohn’s disease |
| 31 | Vertigo |
Part 6 · Diseases attributable to F-111 deseal/reseal work
11Attributable diseases#
(1)For the purposes of this Part, F-111 Tier personnel means a person who has been determined to have Tier 1, Tier 2, or Tier 3 status for the purposes of Group 1 participation in the Study of Health Outcomes in Aircraft Maintenance Personnel (SHOAMP) Health Care Scheme administered by the Department.
(2)A disease specified in the table is attributable to defence service as a F-111 Tier personnel.
| Item | Disease |
| 1 | Acquired colour vision deficiency |
| 2 | Agoraphobia with panic disorder |
| 3 | Anxiety |
| 4 | Bipolar disorder |
| 5 | Bowel polyps |
| 6 | Cauda equina syndrome |
| 7 | Depression |
| 8 | Diverticular disease |
| 9 | Dysplastic naevus |
| 10 | Eczema or dermatitis |
| 11 | Erectile dysfunction |
| 12 | Impaired cognition |
| 13 | Irritable bowel disorder |
| 14 | Liver disease (excluding diabetes) |
| 15 | Memory loss |
| 16 | Mixed connective tissue disease |
| 17 | Multiple sclerosis |
| 18 | Myeloproliferative disorders |
| 19 | Neurogenic bladder |
| 20 | Non-alcoholic toxic encephalopathy |
| 21 | Pancreatic disease |
| 22 | Panic disorders |
| 23 | Parkinson disease |
| 24 | Peripheral neuropathy |
| 25 | Primary malignant neoplasms |
| 26 | Sarcoidosis |
| 27 | Sleep disorders with a neurological basis |
| 28 | Spinal muscular atrophy |
| 29 | Systemic lupus erythematosus |
| 30 | Ulcerative colitis/Crohn’s disease |
| 31 | Vertigo |
Part 7 · Cancers attributable to firefighting work
12Meaning of firefighter#
For the purposes of this Part, a member is taken to have rendered defence service as a firefighter if firefighting or related service made up a substantial portion of the member’s service.
13Attributable diseases#
A disease specified in column 1 of an item in the table is attributable to the kind of defence service specified in column 2 of the item.
| Column 1 | Column 2 | |
| Item | Disease | Kind of defence service |
| 1 | Malignant mesothelioma | Defence service:(a) as a firefighter for at least 15 years (whether consecutive or not); and(b) involving exposure to the hazards of a fire scene during that period. |
| 2 | Multiple myeloma | Defence service:(a) as a firefighter for at least 15 years (whether consecutive or not); and(b) involving exposure to the hazards of a fire scene during that period. |
| 3 | Primary leukemia | Defence service:(a) as a firefighter for at least 5 years (whether consecutive or not); and(b) involving exposure to the hazards of a fire scene during that period. |
| 4 | Primary malignant neoplasm of the bladder | Defence service:(a) as a firefighter for at least 15 years (whether consecutive or not); andinvolving exposure to the hazards of a fire scene during that period. |
| 5 | Primary malignant neoplasm of the brain | Defence service:(a) as a firefighter for at least 5 years (whether consecutive or not); and(b) involving exposure to the hazards of a fire scene during that period. |
| 6 | Primary malignant neoplasm of the breast | Defence service:(a) as a firefighter for at least 10 years (whether consecutive or not); and(b) involving exposure to the hazards of a fire scene during that period. |
| 7 | Primary malignant neoplasm of the cervix | Defence service:(a) as a firefighter for at least 10 years (whether consecutive or not); and(b) involving exposure to the hazards of a fire scene during that period. |
| 8 | Primary malignant neoplasm of the colon or rectum | Defence service:(a) as a firefighter for at least 15 years (whether consecutive or not); and(b) involving exposure to the hazards of a fire scene during that period. |
| 9 | Primary malignant neoplasm of the kidney | Defence service:(a) as a firefighter for at least 15 years (whether consecutive or not); and(b) involving exposure to the hazards of a fire scene during that period. |
| 10 | Primary malignant neoplasm of the lung | Defence service:(a) as a firefighter for at least 15 years (whether consecutive or not); and(b) involving exposure to the hazards of a fire scene during that period. |
| 11 | Primary malignant neoplasm of the oesophagus | Defence service:(a) as a firefighter for at least 15 years (whether consecutive or not); and(b) involving exposure to the hazards of a fire scene during that period. |
| 12 | Primary malignant neoplasm of the ovary | Defence service:(a) as a firefighter for at least 10 years (whether consecutive or not); and(b) involving exposure to the hazards of a fire scene during that period. |
| 13 | Primary malignant neoplasm of the pancreas | Defence service:(a) as a firefighter for at least 10 years (whether consecutive or not); and(b) involving exposure to the hazards of a fire scene during that period. |
| 14 | Primary malignant neoplasm of the penis | Defence service:(a) as a firefighter for at least 15 years (whether consecutive or not); and(b) involving exposure to the hazards of a fire scene during that period. |
| 15 | Primary malignant neoplasm of the prostate | Defence service:(a) as a firefighter for at least 15 years (whether consecutive or not); and(b) involving exposure to the hazards of a fire scene during that period. |
| 16 | Primary malignant neoplasm of the skin | Defence service:(a) as a firefighter for at least 15 years (whether consecutive or not); and(b) involving exposure to the hazards of a fire scene during that period. |
| 17 | Primary malignant neoplasm of the testis | Defence service:(a) as a firefighter for at least 10 years (whether consecutive or not); andinvolving exposure to the hazards of a fire scene during that period. |
| 18 | Primary malignant neoplasm of the thyroid | Defence service:(a) as a firefighter for at least 10 years (whether consecutive or not); and(b) involving exposure to the hazards of a fire scene during that period. |
| 19 | Primary malignant neoplasm of the ureter | Defence service:(a) as a firefighter for at least 15 years (whether consecutive or not); and(b) involving exposure to the hazards of a fire scene during that period. |
| 20 | Primary non-Hodgkin lymphoma | Defence service:(a) as a firefighter for at least 15 years (whether consecutive or not); and(b) involving exposure to the hazards of a fire scene during that period. |
Part 8 · Occupational diseases attributable to specified defence service
14Attributable diseases#
A disease specified in column 1 of an item in the table is attributable to the kind of defence service specified in column 2 of the item.
| Column 1 | Column 2 | |
| Item | Disease | Kind of defence service |
| Infectious diseases | ||
| 1 | Anthrax | Defence service involving work with:(a) animals; or(b) animal carcasses; or(c) animal parts. |
| 2 | Brucellosis | Defence service involving work with:(a) animals; or(b) animal carcasses; or(c) animal parts; or(d) animal waste. |
| 3 | Hepatitis A | Defence service involving work with human waste. |
| 4 | Hepatitis B or Hepatitis C | Defence service involving work with human body fluids. |
| 5 | Human Immunodeficiency Virus (HIV) or Acquired Immune Deficiency Syndrome (AIDS) | Defence service involving work with:(a) needles in a healthcare services setting; or(b) sharps in a healthcare services setting. |
| 6 | Leptospirosis | Defence service involving work with:(a) animals; or(b) animal carcasses; or(c) animal parts; or(d) animal waste. |
| 7 | Orf | Defence service involving work with:(a) goats; or(b) goat carcasses; or(c) sheep; or(d) sheep carcasses. |
| 8 | Q-fever | Defence service involving work with:(a) animals; or(b) animal carcasses; or(c) animal parts. |
| 9 | Tuberculosis | Defence service involving work with:(a) animals:(i) in a farming setting; or(ii) in a veterinarian setting; or(b) animal carcasses:(i) in a farming setting; or(ii) in a veterinarian setting; or(c) human corpses:(i) in a healthcare services setting; or(ii) in a mortuary setting; or(d) persons (individuals) in a healthcare services setting. |
| Malignant diseases | ||
| 10 | Primary malignant neoplasm of the salivary gland | Defence service for at least 5 years (whether consecutive or not) involving work with:(a) equipment that produces ionising radiation; or(b) substances that emit ionising radiation. |
| 11 | Primary malignant neoplasm of the nasopharynx | Defence service for at least 5 years (whether consecutive or not) involving work with:(a) formaldehyde; or(b) wood. |
| 12 | Primary malignant neoplasm of the oesophagus | Defence service for at least 5 years (whether consecutive or not) involving work with:(a) equipment that produces ionising radiation; or(b) substances that emit ionising radiation. |
| 13 | Primary malignant neoplasm of the stomach | Defence service for at least 5 years (whether consecutive or not) involving work with:(a) equipment that produces ionising radiation; or(b) substances that emit ionising radiation. |
| 14 | Primary malignant neoplasm of the colon or rectum | Defence service for at least 5 years (whether consecutive or not) involving work with:(a) equipment that produces ionising radiation; or(b) substances that emit ionising radiation. |
| 15 | Primary malignant neoplasm of the liver | Defence service for at least 5 years (whether consecutive or not) involving work with vinyl chloride monomer. |
| 16 | Primary malignant neoplasm of the nasal cavity or para-nasal sinuses | Defence service for at least 5 years (whether consecutive or not) involving work with:(a) equipment that produces ionising radiation; or(b) substances that emit ionising radiation; or(c) nickel; or(d) leather; or(e) wood. |
| 17 | Primary malignant neoplasm of the larynx | Defence service for at least 5 years (whether consecutive or not) involving work with:(a) asbestos; or(b) asbestos-containing material; or(c) acid mist (strong inorganic). |
| 18 | Primary malignant neoplasm of the lung caused by asbestos | Defence service for at least 5 years (whether consecutive or not) involving work with:(a) asbestos; or(b) asbestos-containing material. |
| 19 | Primary malignant neoplasm of the bone | Defence service for at least 5 years (whether consecutive or not) involving work with:(a) equipment that produces ionising radiation; or(b) substances that emit ionising radiation. |
| 20 | Primary malignant neoplasm of the mesothelium | Defence service for at least one year (whether consecutive or not) involving work with:(a) asbestos; or(b) asbestos-containing material. |
| 21 | Primary malignant neoplasm of the breast | Defence service for at least 5 years (whether consecutive or not) involving work with:(a) equipment that produces ionising radiation; or(b) substances that emit ionising radiation. |
| 22 | Primary malignant neoplasm of the ovary | Defence service for at least 5 years (whether consecutive or not) involving work with:(a) asbestos; or(b) asbestos-containing material. |
| 23 | Primary malignant neoplasm of the kidney | Defence service for at least 5 years (whether consecutive or not) involving work with:(a) equipment that produces ionising radiation; or(b) substances that emit ionising radiation; or(c) trichloroethylene. |
| 24 | Primary malignant neoplasm of urothelial tissue lining the urinary tract | Defence service for at least 5 years (whether consecutive or not) involving work with:(a) equipment that produces ionising radiation; or(b) substances that emit ionising radiation; or(c) 2-naphthylamine; or(d) benzidine; or(e) cyclophosphamide; or(f) ortho-toluidine; or(g) polycyclic aromatic hydrocarbons during aluminium production. |
| 25 | Primary malignant neoplasm of the brain | Defence service for at least 5 years (whether consecutive or not) involving work with:(a) equipment that produces ionising radiation; or(b) substances that emit ionising radiation. |
| 26 | Primary malignant neoplasm of the thyroid | Defence service for at least 5 years (whether consecutive or not) involving work with:(a) equipment that produces ionising radiation; or(b) substances that emit ionising radiation. |
| 27 | Primary leukaemia (excluding chronic lymphatic leukaemia) | Defence service for at least 2 years (whether consecutive or not) involving work with:(a) equipment that produces ionising radiation; or(b) substances that emit ionising radiation; or(c) benzene; or(d) butadiene; or(e) cyclophosphamide; or(f) formaldehyde. |
| 28 | Primary non-Hodgkin lymphoma | Defence service for at least 2 years (whether consecutive or not) involving work with:(a) equipment that produces ionising radiation; or(b) substances that emit ionising radiation. |
| Diseases of the nervous system | ||
| 29 | Parkinson disease | Defence service for at least one year (whether consecutive or not) involving work with manganese. |
| 30 | Peripheral neuropathy | Defence service for at least one year (whether consecutive or not) involving work with:(a) acrylamide; or(b) arsenic; or(c) carbon disulphide; or(d) lead; or(e) mercury; or(f) n-hexane; or(g) organophosphates; or(h) trichloroethylene. |
| Respiratory diseases | ||
| 31 | Coal workers’ pneumoconiosis | Defence service for at least 5 years (whether consecutive or not) involving work with coal. |
| 32 | Asbestosis | Defence service for at least 5 years (whether consecutive or not) involving work with:(a) asbestos; or(b) asbestos-containing material. |
| 33 | Silicosis | Defence service for at least 5 years (whether consecutive or not) involving work with:(a) material containing crystalline silica; or(b) silica. |
| 34 | Other pneumoconiosis | Defence service for at least 5 years (whether consecutive or not) involving work with:(a) aluminium; or(b) barium; or(c) beryllium; or(d) cobalt; or(e) iron oxide; or(f) tin; or(g) tungsten. |
| 35 | Byssinosis | Defence service for at least 4 weeks (whether consecutive or not) involving work with:(a) unprocessed cotton; or(b) unprocessed flax; or(c) unprocessed hemp; or(d) unprocessed sisal. |
| 36 | Extrinsic allergic alveolitis | Defence service for at least 4 weeks (whether consecutive or not) involving work with:(a) feathers; or(b) grain; or(c) hay; or(d) straw. |
| Hepatic disease | ||
| 37 | Non-infectious hepatitis | Defence service involving work with:(a) acrylonitrile; or(b) alcohols; or(c) amino-derivatives of benzene; or(d) antimony; or(e) aromatic hydrocarbons; or(f) arsenic; or(g) benzene; or(h) benzoquinone; or(i) beryllium; or(j) cadmium; or(k) carbon disulphide; or(l) carbon monoxide; or(m) chromium; or(n) copper; or(o) fluorine; or(p) glycols; or(q) hexane; or(r) hydrogen cyanide; or(s) hydrogen sulphide; or(t) ketones; or(u) lead; or(v) manganese; or(w) mercury; or(x) methylene chloride; or(y) mineral acids; or(z) nitric acid esters; or(za) organochlorine compounds; or(zb) organophosphate; or(zc) osmium; or(zd) oxides of nitrogen; or(ze) ozone; or(zf) phosgene; or(zg) phosphorus; or(zh) selenium; or(zi) styrene; or(zj) thallium; or(zk) tin; or(zl) toluene; or(zm) toxic halogen derivatives of aliphatic; or(zn) toxic nitro-derivatives of benzene; or(zo) vanadium; or(zp) zinc. |
| Skin diseases | ||
| 38 | Irritant contact dermatitis | Defence service for at least 4 weeks (whether consecutive or not) involving work and contact with:(a) alcohols; or(b) cutting fluids; or(c) cleaners; or(d) degreasers; or(e) disinfectants; or(f) liquids (frequent contact); or(g) liquids (prolonged contact); or(h) petroleum products; or(i) soaps; or(j) solvents. |
| 39 | Allergic contact dermatitis | Defence service for at least 4 weeks (whether consecutive or not) involving work and contact with:(a) 2,5-diaminotoluene sulfate; or(b) 4-phenylenediamine base; or(c) ammonium persulfate; or(d) cobalt chloride; or(e) cocamide diethanolamide; or(f) coconut diethanolamide; or(g) colophonium/colophony/rosin; or(h) diazolidinyl urea; or(i) epoxy resin; or(j) formaldehyde; or(k) fragrance mix I:(i) amylcinnamaldehyde; or(ii) cinnamic alcohol; or(iii) cinnamic aldehyde;(iv) eugenol; or(v) geraniol; or(vi) hydroxycitronellal; or(vii) isoeugenol; or(viii) oakmoss absolute; or(l) fragrance mix II:(i) citral; or(ii) citronellol; or(iii) coumarin; or(iv) farnesol; or(v) hexyl cinnamic aldehyde; or(vi) hydroxyisohexyl 3-cyclohexene carboxaldehyde; or(m) glyceryl monothioglycolate; or(n) hydroxyethyl methacrylate; or(o) mercaptobenzothiazole; or(p) methyl chloroisothiazolinone; or(q) mixture of methylchloroisothiazolinone and methylisothiazolinone; or(r) nickel sulfate; or(s) potassium dichromate; or(t) quaternium 15; or(u) thiuram mix:(i) tetramethylthiuramdisulfide; or(ii) tetramethylthiuram monosulfide; or(iii) tetraethylthiuram disulfide. |
| 40 | Occupational vitiligo | Defence service for at least 4 weeks (whether consecutive or not) involving work with:(a) hydroquinone; or(b) monobenzyl ether of hydroquinone; or(c) monobutyl ether of hydroquinone; or(d) para-amylphenol; or(e) para-tertiary-butylcatechol; or(f) para-tertiary-butylphenol. |
| Musculoskeletal diseases | ||
| 41 | Raynaud’s disease | Defence service for at least 12 weeks (whether consecutive or not) involving work with:(a) powered equipment that produces vibration; or(b) powered tools that produce vibration. |
| 42 | Bursitis at the elbow or knee | Defence service for at least 6 months (whether consecutive or not) involving a work activity that:(a) for bursitis at the elbow:(i) involves prolonged external friction at or about the elbow; or(ii) involves prolonged external pressure at or about the elbow; or(iii) involves recurrent external friction at or about the elbow; or(iv) involves recurrent external pressure at or about the elbow; or(b) for bursitis at the knee:(i) involves prolonged external friction at or about the knee; or(ii) involves prolonged external pressure at or about the knee; or(iii) involves recurrent external friction at or about the knee; or(iv) involves recurrent external friction at or about the knee. |
| Acute diseases | ||
| 43 | Acute poisoning or toxicity affecting the heart, lungs, liver, kidney, nervous system or blood | The same as for item 37. |
Part 9 · Occupational asthma attributable to specified defence service
15Attributable disease—occupational asthma#
The disease of occupational asthma is attributable to defence service for at least 4 weeks (whether consecutive or not) involving work with an agent or thing specified in column 2 of an item in the table.
| Column 1 | Column 2 | |
| Item | Class of agent or thing | Specified agent or thing |
| 1 | Arthropods | (a) acarian; or(b) barn mite; or(c) caddisfly; or(d) cricket; or(e) Ephestia kuehniella (Mediterranean flour moth); or(f) fowl mite; or(g) fruit fly; or(h) grain mite; or(i) flour mite; or(j) lesser mealworm; or(k) locust; or(l) sheep blowfly; or(m) silkworm. |
| 2 | Acids | (a) dodecanedioic acid; or(b) glacial acetic acid; or(c) hydrochloric acid; or(d) peroxyacetic acid; or(e) sulphuric acid; or(f) sulphur dioxide. |
| 3 | Acrylates | (a) acrylic acid; or(b) cyanoacrylates; or(c) methyl methacrylate; or(d) polymethyl methacrylate; or(e) trimethylolpropane triacrylate/2-hydroxypropyl acrylate. |
| 4 | Aldehydes | (a) formaldehyde; or(b) gluteraldehyde; or(c) paraformaldehyde; or(d) urea formaldehyde. |
| 5 | Amines | (a) aminoethyl ethanolamine; or(b) diethanolamine; or(c) dimethylethanolamine; or(d) ethanolamines; or(e) ethylenediamine; or(f) monoethanolamine; or(g) surfactant-specific amines; or(h) triethanolamine; or(i) triethylenetetramine; or(j) trimethylhexane-1; or(k) 6-diamine/isophorondiamine mixture. |
| 6 | Ammonias | (a) anhydrous ammonia; or(b) ammonium hydroxide; or(c) ammonia solution 10%; or(d) ammonia solution 29%. |
| 7 | Anhydrides | (a) hexahydrophthalic anhydride; or(b) himic anhydride; or(c) maleic anhydride; or(d) methyl tetrahydrophthalic; or(e) anhydride; or(f) phthalic anhydride; or(g) tetrachlorophthalic anhydride; or(h) trimellitic anhydride. |
| 8 | Bio-aerosols | (a) Alternaria; or(b) Chrysonilia sitophilia; or(c) Neurospora; or(d) Penicillium; or(e) cutting oils. |
| 9 | Biological enzymes | (a) Bacillus subtilis enzymes; or(b) bromelain; or(c) egg lysozyme; or(d) esperase; or(e) flaviastase; or(f) fungal amylase; or(g) fungal amyloglucosidase; or(h) fungal hemicellulose; or(i) pancreatin; or(j) papain; or(k) pepsin; or(l) trypsin. |
| 10 | Epoxy | (a) epoxy; or(b) epoxy adhesive. |
| 11 | Ethylene oxide | ethylene oxide. |
| 12 | Flours | (a) buckwheat flour; or(b) rye flour; or(c) soya flour; or(d) wheat flour. |
| 13 | Flowers | (a) baby’s breath; or(b) freesia; or(c) Limonium tataricum; or(d) sunflower. |
| 14 | Foods | (a) Brazil ginseng; or(b) castor bean; or(c) chamomile; or(d) cinnamon; or(e) Dioscorea batatas (Chinese yam); or(f) egg protein; or(g) fenugreek; or(h) garlic dust; or(i) green beans; or(j) guar; or(k) hops; or(l) paprika; or(m) pectin; or(n) rose hips; or(o) soybean lecithin; or(p) tea; or(q) thiamine (vitamin B); or(r) thyme. |
| 15 | Industrial cleaning and sterilising agents | (a) alkyl dimethyl benzyl ammonium chloride; or(b) benzyl-C10-16-alkyldimethyl, chlorides; or(c) benzyl-C12-16-alkyldimethyl, chlorides; or(d) benzyl-C12-18-alkyldimethyl, chlorides; or(e) benzyl-C16-18-alkyldimethyl, chlorides; or(f) benzyldimethylstearyl ammonium chloride; or(g) cetalkonium chloride; or(h) chlorhexidine; or(i) chlorine; or(j) dialkyl methyl benzyl ammonium chloride; or(k) dicumyl-peroxide; or(l) dodecyl dimethyl ammonium chloride; or(m) dimethyl ethyl benzyl ammonium chloride; or(n) dodecyl-dimethylbenzylammonium; or(o) fluorine; or(p) n-alkyl dimethyl benzyl ammonium chloride; or(q) persulphate salts; or(r) sodium hypochlorite; or(s) sodium metabisulfite. |
| 16 | Isocyanates | (a) diisocyanates; or(b) hexamethylene diisocyanate prepolymers; or(c) isocyanates; or(d) toluene diisocyanate prepolymers. |
| 17 | Latex | (a) latex; or(b) natural rubber. |
| 18 | Medications | (a) ampicillin; or(b) amprolium; or(c) cimetidine; or(d) codeine; or(e) colistin; or(f) hydralazine; or(g) ipecacuanha; or(h) hydrocodone; or(i) isonicotinic acid hydrazide; or(j) methyldopa; or(k) morphine; or(l) opiate compounds; or(m) oxycodone; or(n) papaverine; or(o) penicillamine; or(p) penicillins; or(q) phenylglycine acid chloride; or(r) psyllium; or(s) salbutamol intermediate; or(t) spiramycin; or(u) tetracycline; or(v) thebaine; or(w) tylosin tartrate; or(x) vancomycin. |
| 19 | Metals | (a) aluminium; or(b) aluminium chloride; or(c) aluminium oxide; or(d) aluminium compounds; or(e) ammonium dichromate; or(f) ammonium hexachloroplatinate (IV); or(g) chromium; or(h) chromium, metal; or(i) chromium, hexavalent; or(j) chromium, non-hexavalent; or(k) cobalt; or(l) cobalt compounds; or(m) nickel; or(n) nickel compounds; or(o) platinum; or(p) rhodium; or(q) soluble halogenated platinum compounds; or(r) titanium oxide/dioxide; or(s) tributyl tin oxide; or(t) tungsten carbide; or(u) tungsten carbide/cobalt; or(v) vanadium; or(w) welding fumes – gas metal arc welding on uncoated mild steel; or(x) welding fumes – stainless steel; or(y) stainless steel; or(z) zinc oxide. |
| 20 | Other reactive chemicals | (a) chlorofluorocarbon refrigerants heated; or(b) fluoride; or(c) furfuryl alcohol mixed with a catalyst; or(d) isolyzer; or(e) polyethylene terephthalate/polybutylene terephthal; or(f) polyfunctional aziridine; or(g) polypropylene heated; or(h) polyvinyl chloride heated; or(i) polyvinyl chloride non-heated; or(j) polyvinyl chloride thermally degraded; or(k) radiographic fixative; or(l) resin containing furfuryl alcohol; or(m) styrene; or(n) trigylicidyl isocyanurate. |
| 21 | Pesticides | (a) 3-amino-5-mercapto-1;2;4-triazole; or(b) acephate; or(c) chloramine T; or(d) chlorothalonil (bravo, echo); or(e) diazinon; or(f) dimethoate; or(g) fenthion; or(h) malathion; or(i) nemacur; or(j) piperazine; or(k) piperazine citrate; or(l) piperazine hydrochloride; or(m) pyrethrins; or(n) pyrfon; or(o) safrotin; or(p) tetramethrin. |
| 22 | Plants and sensitising agents or irritants derived from plants | (a) almond dust; or(a) Arabidopsis thaliana; or(b) Chlorella algae; or(c) gum arabic; or(d) henna; or(e) kapok; or(f) linseed oilcake; or(g) Pinellia ternata; or(h) quillaja bark; or(i) rice dust; or(j) tall oil crude; or(k) tall oil – rosin; or(l) tobacco leaf; or(m) tragacanth; or(n) turpentine; or(o) Vicia sativa (vetch); or(p) weeping fig. |
| 23 | Reactive dyes | (a) Cibachrome Brilliant Scarlet 32; or(b) Drimarene Brilliant Blue K-BL; or(c) Drimarene Brilliant Yellow K-3GL; or(d) Lanasol Yellow 4G; or(e) Levafix Brilliant Yellow E36; or(f) Methyl Blue; or(g) Rifacion Orange HE 2G; or(h) Rifafix Yellow 3 RN; or(i) Rifazol Black GR; or(j) Rifazol Brilliant Orange 3R. |
| 24 | Sensitising agents or irritants derived from animals | (a) bat guano; or(b) bovine serum albumin; or(c) casein; or(d) cat antigens; or(e) chicken antigens; or(f) cow antigens; or(g) frog antigens; or(h) guinea pig antigens; or(i) lactoserum; or(j) mice antigens; or(k) pig antigens; or(l) rabbit antigens; or(m) rat antigens. |
| 25 | Sensitising agents or irritants derived from fish or shellfish | (a) Anisakis simplex (herring worm) antigens; or(b) clam antigens; or(c) crab antigens; or(d) cuttlefish antigens; or(e) fishmeal; or(f) nacre dust; or(g) octopus antigens; or(h) prawn antigens; or(i) red soft coral antigens; or(j) salmon antigens; or(k) shrimp meal; or(l) trout antigens. |
| 26 | Soldering fluxes | (a) colophony soldering flux; or(b) alkyl aryl polyether soldering flux; or(c) zinc soldering flux. |
| 27 | Wood | (a) Triplochiton scleroxylon (African maple); or(b) Acacia melanoxylon (blackwood); or(c) Sequoia sempervirens (California redwood); or(d) Juglans olanchana (Central American walnut); or(e) Thuja occidentalis (eastern white cedar); or(f) Shoreal sp. (mahogany); or(g) Quercus robur (oak); or(h) Thuja lpicata (western red cedar). |
Sourced from the Federal Register of Legislation at legislation.gov.au, © Commonwealth of Australia, licensed under CC BY 4.0. Compilations may have been reformatted.